At the news
? BEARISHIMPACT 7/10 424B5 filed Apr 23, 2026 at 07:30 ET
Outlook Therapeutics is raising $4.65 million through a registered offering of 16.1 million shares at $0.31 per share, accompanied by warrants to purchase an equal number of shares at the same price. The proceeds will extend the company's cash runway into August 2026, but substantial doubt remains about its ability to continue as a going concern. The company also amended existing warrants to lower their exercise price from $2.26 to $0.31, reflecting financial distress.
- Offering 16,129,033 shares at $0.31 per share, raising gross proceeds of $5 million
- Concurrent private placement of warrants to purchase 16,129,033 shares at $0.31 per share
- Net proceeds estimated at $4.65 million after placement agent fees
- Company has substantial doubt about its ability to continue as a going concern
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access